A history of vitamin e

Annals of Nutrition and Metabolism

Volumn 61, Issue 3, 2012, Pages 207-212

  Niki, Etsuo ^a   Traber, Maret G ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Ataxia with vitamin E deficiency; Chain breaking antioxidant; Tocopherols; Tocotrienols

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; PEROXY RADICAL;

ALPHA TOCOPHEROL DEFICIENCY; ANTIOXIDANT ACTIVITY; BILAYER MEMBRANE; DRUG POTENTIATION; FOOD INTAKE; FRIEDREICH ATAXIA; HUMAN; LIPID PEROXIDATION; MALABSORPTION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVIEW; VITAMIN METABOLISM;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; CARRIER PROTEINS; HISTORY, 20TH CENTURY; HUMANS; TOCOTRIENOLS; VITAMIN E DEFICIENCY;

RATTUS;

EID: 84870371797     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000343106     Document Type: Review

References (45)

1. Evans HM, Bishop KS: On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922; 56: 650-651.
2. Olcott HS, Mattill HA: The unsaponifiable lipids of lettuce: III. Antioxidant. J Biol Chem 1931; 93: 65-70.
3. Mattill HA: Antioxidants. Annu Rev Bio-chem 1947; 16: 177-192.
4. Tappel AL: The inhibition of hematin-cata-lyzed oxidations by alpha-tocopherol. Arch Biochem Biophys 1953; 47:223-225.
5. Burton GW, Ingold KU: Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure a nd fu nction. Acc Chem Res 1986; 19: 194-201.
6. Niki E: Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 1987; 44: 227-253.
7. Packer JE, Slater TF, Willson RL: Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979; 278: 737-738.
8. Niki E, Noguchi N: Dynamics of antioxidant action of vitamin E. Acc Chem Res 2004; 37: 45-51.
9. Bowry VW, Ingold KU, Stocker R: Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-ox-idant. Biochem J 1992; 288: 341-344.
10. Bowry V W, Mohr D, Cleary J, Stocker R: P re-vention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipo-protein. J Biol Chem 1995; 270:5756-5763.
11. Saito Y, Nishio K, Akazawa YO, Yamanaka K, Miyama A, Yoshida Y, Noguchi N, Niki E: Cytoprotective effect of vitamin E homologues against glutamate-induced cell death in immature primary cortical neuron cultures: tocopherols and tocotrienols exert similar effects by antioxidant function. Free Radic Biol Med 2010; 49:1542-1549.
12. Gallo-Torres HE: Transport and metabolism; in Machlin LJ (ed): Vitamin E: A Comprehensive Treatise. New York, Marcel Dekker, 1980, pp 193-267.
13. Liebler DC, Burr JA, Philips L, Ham AJ: Gas chromatography-mass spectrometry analysis of vitamin E and its oxidation products. Anal Biochem 1996; 236:27-34.
14. Murphy ME, Kolvenbach R, Aleksis M, Hansen R, Sies H: Antioxidant depletion in aortic crossclamping ischemia: increase of the plasma alpha-tocopheryl quinone/alpha-to-copherol ratio. Free Radic Biol Med 1992; 13: 95-100.
15. Shi H, Noguchi N, Niki E: Comparative study on dynamics of antioxidative action of alpha-tocopheryl hydroquinone, ubiquinol, and alpha-tocopherol against lipid peroxidation. Free Radic Biol Med 1999; 27:334-346.
16. Atkinson J, Epand RF, Epand RM: Tocoph-erols and tocotrienols in membranes: a critical review. Free Radic Biol Med 2008; 44: 739-764.
17. Evans HM, Emerson OH, Emerson GA: The isolation from wheat germ oil of an alcohol, alpha-tocopherol, having the properties of vitamin E. J Biol Chem 1936; 113:319-332.
18. Emerson OH, Emerson GA, Mohammad A, Evans HM: The chemistry of vitamin E. To-copherols from natural sources. J Biol Chem 1937; 22: 99-107.
19. Machlin LJ, Gabriel E, Brin M: Biopotency of alpha-tocopherols as determined by curative myopathy bioassay in the rat. J Nutr 1982; 112:1437-1440.
20. Traber MG, Atkinson J: Vitamin E, antioxi-dant and nothing more. Free Radic Biol Med 2007; 43:4-15.
21. Cornwell DG, Williams MV, Wani AA, Wani G, Shen E, Jones KH: Mutagenicity of tocopheryl quinones: evolutionary advantage of selective accumulation of dietary al-pha-tocopherol. Nutr Cancer 2002; 43:111-118.
22. Machlin LJ: Vitamin E: A Comprehensive Treatise. New York, Marcel Dekker, 1980.
23. Horwitt MK, Harvey CC, Duncan GD, Wilson WC: Effects of limited tocopherol intake in man with relationships to erythrocyte he-molysis and lipid oxidations. Am J Clin Nutr 1956; 4:408-419.
24. Binder HJ, Spiro HM: Tocopherol deficiency in ma n. Am J Clin Nutr 1967; 20: 594-603.
25. Kayden HJ, Silber R, Kossmann CE: The role of vitamin E deficiency in the abnormal au-tohemolysis of acanthocytosis. Trans Assoc Am Physicians 1965; 78:334-342.
26. Stumpf DA, Sokol R, Bettis D, Neville H, Ringel S, Angelini C, Bell R: Fr iedreich 's d is-ease: V. Variant form with vitamin E deficiency and normal fat absorption. Neurology 1987; 37: 68-74.
27. Sokol RJ, Kayden HJ, Bettis DB, Traber MG, Neville H, Ringel S, Wilson WB, Stumpf DA: Isolated vitamin E deficiency in the absence of fat malabsorption-familial and sporadic cases: characterization and investigation of causes. J Lab Clin Med 1988; 111: 548-559.
28. Nelson JS, Fitch CD, Fischer VW, Brown GO Jr, Chou AC: Progressive neuropathologic lesions in vitamin E deficient rhesus monkeys. J Neuropat hol Exp Neurol 1981; 40: 166-185.
29. Traber MG, Burton GW, Ingold KU, Kayden HJ: RRR-and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density li-poproteins. J Lipid Res 1990; 31: 675-685.
30. Traber MG, Burton GW, Hughes L, Ingold KU, Hidaka H, Malloy M, Kane J, Hyams J, Kayden JH: Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J Lipid Res 1992; 33:1171-1182.
31. Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, Huffaker JE, Kayden HJ: Impaired ability of patients with familial isolated vitamin E deficiency to incorporate al-pha-tocopherol into lipoproteins secreted by the liver. J Clin Invest 1990; 85: 397-407.
32. Traber MG, Sokol RJ, Kohlschütter A, Yoko-ta T, Muller DP, Dufour R, Kayden JH: Impaired discrimination between stereoiso-mers of a lpha-tocopherol in pat ients w it h familial isolated vitamin E deficiency. J Lipid Res 1993; 34: 201-210.
33. Catignani GL, Bieri JG: Rat liver alpha-to-copherol binding protein. Biochim Biophys Acta 1977; 497: 349-357.
34. Sato Y, Hagiwara K, Arai H, Inoue K: Purification and characterization of the alpha-to-copherol transfer protein from rat liver. FEBS Lett 1991; 288:41-45.
35. Sato Y, Arai H, Miyata A, Tokita S, Yama-moto K, Tanabe T, Inoue K: Primary structure of alpha-tocopherol transfer protein from rat liver. Homology with cellular reti-naldehyde-binding protein. J Biol Chem 1993; 268:17705-17710.
36. Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H, Inoue K: Affinity for alpha-tocopherol transfer protein as a determinant of the biolog ica l activities of vita min E analogs. FEBS Lett 1997; 409:105-108.
37. Min KC, Kovall RA, Hendrickson WA: Crystal structure of human alpha-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin E deficiency. Proc Natl Acad Sci USA 2003; 100:14713-14718.
38. Yokota T, Igarashi K, Uchihara T, Jishage K, Tomita H, Inaba A, Li Y, Arita M, Suzuki H, Mizusawa H, Arai H: Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc Natl Acad Sci USA 2001; 98:15185-15190.
39. Leonard SW, Terasawa Y, Farese RV Jr, Traber MG: Incorporation of deuterated RRR-or all-rac-alpha-tocopherol into plasma and tissues of alpha-tocopherol transfer protein-nul l mice. Am J Clin Nutr 2002; 75: 555-560.
40. Ben Hamida C, Doerflinger N, Belal S, Linder C, Reutenauer L, Dib C, Gyapay G, Vignal A, Le Paslier D, Cohen D, et al: Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat Genet 1993; 5: 195-200.
41. Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R, Arai H, Inoue K, Mandel JL, Koenig M: Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 1995; 9: 141-145.
42. Di Donato I, Bianchi S, Federico A: Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol Sci 2010; 31: 511-515.
43. Schultz M, Leist M, Petrzika M, Gassmann B, Brigelius-Flohé R: Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2'- carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply? Am J Clin Nutr 1995; 62(suppl):1527S-1534S.
44. Sontag TJ, Parker RS: Influence of major structural features of tocopherols and tocot-rienols on their omega-oxidation by tocoph-erol-omega- hydroxylase. J Lipid Res 2007; 48:1090-1098.
45. Swanson JE, Ben RN, Burton GW, Parker RS: Urinary excretion of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman is a major route of elimination of gamma-to-copherol in humans. J Lipid Res 1999; 40: 665-671.